A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients - Related Studies

A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients (AMICI)

This study has been terminated.

( This study was terminated early due to poor enrollment. )

Study NCT00488059 Information provided by Hoffmann-La Roche

First Received on June 18, 2007. Last Updated on July 18, 2011 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

HIV Infections

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Enfuvirtide
Integrase Inhibitors

More general drug interventions related to this trial

Sponsors listed in this trial

Hoffmann-La Roche
Trimeris